Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Myobloc in the Treatment of Sialorrhea (Drooling) in Patients With Amyotrophic Lateral Sclerosis (ALS)
This study is ongoing, but not recruiting participants.
Study NCT00125203 Information provided by The University of Texas Health Science Center at San Antonio
First Received: July 27, 2005 Last Updated: May 7, 2007
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Amyotrophic Lateral Sclerosis
Sialorrhea
Additional conditions recognized in this trial
Motor Neuron Disease
Sclerosis
More general conditions related to this trial
Central Nervous System Diseases
Mouth Diseases
Nervous System Diseases
Neurodegenerative Diseases
Neuromuscular Diseases
Pathologic Processes
Salivary Gland Diseases
Spinal Cord Diseases
Stomatognathic Diseases
Interventions listed in this trial
Botulinum toxin type B (Myobloc)
Injection of salivary glands
Additional drug interventions recognized in this trial
Botulinum Toxins
More general drug interventions related to this trial
Anti-Dyskinesia Agents
Central Nervous System Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
The University of Texas Health Science Center at San Antonio
ALS Association
University of Kansas
Carolinas MDA Neuromuscular/ALS Center-Carolinas Medical System
Back to top of Main Content